✦ LIBER ✦

Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation

✍ Scribed by C. Noel Bairey Merz; B. Delia Johnson; Sarah Berga; Glenn Braunstein; Steven E. Reis; Vera Bittner

Book ID: 116468741
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 141 KB
Volume: 85
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2006.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association between the Severity of Angi

Association between the Severity of Angiographic Coronary Artery Disease and Paraoxonase Gene Polymorphisms in the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study

✍ Qi Chen; Steven E. Reis; Candace M. Kammerer; Dennis M. McNamara; Richard Holubk 📂 Article 📅 2003 🏛 American Society of Human Genetics 🌐 English ⚖ 120 KB

Adverse outcomes among women presenting

Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory

✍ Sharaf, Barry; Wood, Todd; Shaw, Leslee; Johnson, B. Delia; Kelsey, Sheryl; Ande 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 438 KB

Aldosterone inhibition and coronary endo

Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation

✍ Bavry, Anthony A.; Handberg, Eileen M.; Huo, Tianyao; Lerman, Amir; Quyyumi, Ars 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Prognosis in women with myocardial ische

Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease. Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE)

✍ B. Johnson; L. Shaw; S. Buchthal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 31 KB

A randomized controlled trial of low-dos

A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: Results from the National Institutes of Health/National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE)

✍ C. Noel Bairey Merz; Marian B. Olson; Candace McClure; Yu-Ching Yang; James Symo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Multimarker Approach Predicts Adverse Ca

Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome Evaluation

✍ Christopher B. Arant; Timothy R. Wessel; Paul M. Ridker; Marian B. Olson; Steven 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB